July « 2015 « Science and Enterprise

Global Threat Identification Methods Sought in Challenge

By Alan, on July 24th, 2015%

(Oxfam East Africa, Wikimedia Commons)

24 July 2015. A new challenge on InnoCentive is seeking techniques for identifying climatic events in one region that have direct or indirect impacts elsewhere in the world. The competition has a total purse of $30,000 and deadline for submissions of 17 September 2015.

InnoCentive in Waltham, Massachusetts . . . → Read More: Global Threat Identification Methods Sought in Challenge

Research, Finance Alliance to Fast-Track Alzheimer’s Drugs

By Alan, on July 24th, 2015%

Ray Dolby (Dolby Family Ventures)

24 July 2015. A coalition of research institute, venture capital firm, and drug discovery company is forming a new enterprise to develop therapy candidates for Alzheimer’s disease from promising lab results. Financial terms of the partnership of Gladstone Institutes and Dolby Family Ventures in San Francisco with Evotec . . . → Read More: Research, Finance Alliance to Fast-Track Alzheimer’s Drugs

Cancer Specialists Offer Plan to Reduce Drug Prices

By Alan, on July 23rd, 2015%

(PublicDomainPictures, Pixabay)

23 July 2015. A group of 118 cancer specialists proposed steps to reduce the cost of drugs to cancer patients, calling the current system of drug pricing “unsustainable and not affordable for many patients.” Their recommendations appear today in a commentary published in the journal Mayo Clinic Proceedings.

Pharmaceutical industry representatives, . . . → Read More: Cancer Specialists Offer Plan to Reduce Drug Prices

Dental Implants Found Prone to Fractures

By Alan, on July 22nd, 2015%

Keren Shemtov-Yona (American Technion Society)

22 July 2015. A review of manufactured dental implants discarded because of bone loss in the jaw of their wearers, indicates more than 6 in 10 of the devices had cracks or similar mechanical defects. The findings from the study by Keren Shemtov-Yona, a dentist and engineering doctoral . . . → Read More: Dental Implants Found Prone to Fractures

Cough Diagnostics Mobile App in Clinical Trial

By Alan, on July 22nd, 2015%

(Ryan Boren, Flickr)

22 July 2015. A smartphone app designed to diagnose the nature of a cough by the sound it makes is now being tested in a clinical trial in Australia. The app, developed in the lab of engineering professor Udantha Abeyratne at University of Queensland in Brisbane, Australia was licensed to . . . → Read More: Cough Diagnostics Mobile App in Clinical Trial

Alliance to Collect Mobile Health Data for Clinical Trials

By Alan, on July 21st, 2015%

(JEShoots, Pixabay)

21 July 2015. A partnership between health technology companies developing cloud-based solutions aims to make it easier to collect data from a wide range of mobile apps for clinical studies. Financial aspects of the agreement between digital health platform company Validic and clinical research technology company Medidata were not disclosed.

Validic, . . . → Read More: Alliance to Collect Mobile Health Data for Clinical Trials

Trial Shows Engineered T-Cells Act on Multiple Myeloma

By Alan, on July 21st, 2015%

Multiple myeloma characterized by immature plasma cells (National Library of Medicine, NIH)

21 July 2015. An early-stage clinical trial shows immune system cells from patients with the blood-related cancer multiple myeloma — modified to attack a protein suspected of helping the cancer grow — generated a positive clinical response in most of the . . . → Read More: Trial Shows Engineered T-Cells Act on Multiple Myeloma

Navy Seeks Graphene Nanoribbons for Electricity Distribution

By Alan, on July 20th, 2015%

All electric-powered Zumwalt-class guided-missile destroyer (U.S. Navy, courtesy of General Dynamics)

20 July 2015. The U.S. Navy wants a more efficient way to distribute electric power on its ships, and believes ultrathin ribbons made of graphene may help them do it. The Office of Naval Research awarded an $800,000 grant to the lab . . . → Read More: Navy Seeks Graphene Nanoribbons for Electricity Distribution

Early Test Shows Alzheimer’s Candidate Lowers Brain Deposits

By Alan, on July 20th, 2015%

(Gerry Shaw, EnCor Biotechnology Inc./Wikimedia Commons)

20 July 2015. A drug developed to treat Alzheimer’s disease reduced a large percentage of accumulated harmful peptides and proteins in brains of laboratory mice induced with the disorder. Results of the tests were reported today by the biotechnology company Treventis Corp. in Philadelphia, developer of the . . . → Read More: Early Test Shows Alzheimer’s Candidate Lowers Brain Deposits

Drug Delivery Biotech Raises $101.8 Million in IPO

By Alan, on July 17th, 2015%

(A. Kotok)

17 July 2015. Chiasma Inc., a biotechnology enterprise developing oral therapies to replace injected drugs, raised some $101.8 million in its initial public stock offering. The company — located in Newton, Massachusetts and Jerusalem, Israel — issued 6,365,000 shares at $16.00, and trades on the Nasdaq exchange under the symbol CHMA. . . . → Read More: Drug Delivery Biotech Raises $101.8 Million in IPO

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise